This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Enzo Life Sciences
other brands :
Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis
product type :
antibody
product name :
DNA-PK polyclonal antibody
catalog :
ADI-KAP-PI001-E
quantity :
100 µg
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry
product information
Product ID :
ADI-KAP-PI001
Catalog Number :
ADI-KAP-PI001-E
Product Name :
DNA-PK polyclonal antibody
Host species :
Rabbit
Clonality :
Polyclonal
Product Type :
Antibody
Size :
100 µg
list of Pubmed id :
17251188
SPECIES REACTIVITY :
Human, Mouse, Rat, Hamster
Background :
DNA-dependent protein kinase (DNA-PK) is made up of 3 subunits, 2 Ku proteins, and a large catalytic subunit (DNA-PKcs). In vitro, DNA-PK phosphorylates several transcription factors and other DNA-binding proteins and is believed to act in DNA damage recognition, repair, and transcription.
ALTnames :
DNA-dependent protein kinase
Immunogen :
Synthetic peptide corresponding to a portion of human DNA-PK.
Buffer :
Liquid. In PBS, pH 7.2, containing 50% glycerol and 0.09% sodium azide.
Uses :
Detects a band of ~350kDa by Western blot.
Application Summary :
IHC (PS), WB
Storage :
-20°C
company information
Enzo Life Sciences
5777 Hines Drive
Ann Arbor, MI 48108
Ann Arbor, MI 48108
info-us@enzolifesciences.
https://www.enzolifesciences.com1-800-942-0430
headquarters: USA
Enzo Life Sciences, incorporating ALEXIS® Biochemicals and BIOMOL® International, offers a comprehensive panel of innovative life science reagents. Antibodies, enzymes, proteins, small molecule inhibitors, product libraries, and assay kits are available for research in Cancer, Cell Death, Epigenetics, Genomics, Immunology, Neuroscience, Signal Transduction, and Ubiquitin & Proteasomes, Enabling Discovery in Life Science(tm). Visit www.enzolifesciences.com.
questions and comments
